Add Company
Join Now

Iconovo Revenue and Competitors

License our Company Data API

Lund,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Iconovo's estimated annual revenue is currently $10.3M per year.(i)
  • Iconovo's estimated revenue per employee is $201,000

Employee Data

  • Iconovo has 51 Employees.(i)
  • Iconovo grew their employee count by -9% last year.

Iconovo's People

NameTitleEmail/Phone
1
VP OperationsReveal Email/Phone
2
Chief Technology Officer & FounderReveal Email/Phone
3
Manager Device DevelopmentReveal Email/Phone
4
Analytisk kemistReveal Email/Phone
5
Analytical ChemistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Iconovo?

ICONOVO AB is developing proprietary inhalation products for licensing. We have long experience and track record in the development of dry powder inhalers and offer a comprehensive range of devices to our clients. Our selection of device concepts for dry powder inhalation include a reservoir inhaler, a pre-metered inhaler, a capsule based inhaler and a single dose disposable inhaler. We can also provide formulation development, performance testing, documentation and a complete supply-chain.

keywords:N/A

N/A

Total Funding

51

Number of Employees

$10.3M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Iconovo News

2022-04-20 - Inhaler Devices Market Size, Outlook And Forecast | 3M ...

3M, Bespak, Gerresheimer AG, Hovione, Iconovo AB, Adherium, Cohero Health, Trudell Medical International, Beximco Pharmaceuticals Ltd,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.3M524%N/A
#2
$3.5M532%N/A
#3
$12.8M5826%N/A
#4
$7.7M59-11%N/A
#5
$15.1M63-6%$9.5M